Mononuclear leucocyte function tests in the assessment of the biocompatibility of peritoneal dialysis fluids

Journal of Clinical Pathology

Volumn 52, Issue 12, 1999, Pages 901-909

  Brulez, H F H ^a   Ter Wee, P M ^a   Snijders, S V ^b   Donker, A J M ^a   Verbrugh, H A ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Biocompatibility; Mononuclear leucocyte function; Peritoneal dialysis

Indexed keywords

COMPLEMENT COMPONENT C3 RECEPTOR; FC RECEPTOR; INTERLEUKIN 8; PERITONEAL DIALYSIS FLUID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERICIDAL ACTIVITY; BIOCOMPATIBILITY; CHEMOLUMINESCENCE; COMPARTMENT MODEL; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; MONOCYTE; OSMOTIC STRESS; PERITONEAL DIALYSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033452471     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.12.901     Document Type: Article

References (30)

1. 1 Verbrugh HA. Organisms causing peritonitis. Contrib Nephrol 1990;85:39-48.
2. 2 Verbrugh HA, van Bronswijk H, Oe PL, et al. The fate of phagocytized Staphylococcus epidermidis. Survival and growth in human mononuclear phagocytes as a potential pathogenic mechanism. Zentralbl Bakteriol Hy [A] 1987; 16(suppl):55-65.
3. 3 Brulez HFH, Verbrugh HA. First-line defense mechanisms in the peritoneal cavity during peritoneal dialysis. Perit Dial Int 1995;15(suppl 7):S24-33.
4. 4 Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981;33:130-5.
5. 5 de Fijter CW, Verbrugh HA, Peters ED, et al. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 1993;39:75-80.
6. 6 Alobaidi HM, Coles GA, Davies M, et al. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Nephrol Dial Transplant 1986;1:16-21.
7. 7 Liberek T, Topley N, Jorres A, et al. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. J Am Soc Nephrol 1993;3:1508-15.
8. 8 Wieslander AP, Linden T. Glucose degradation and cytotoxicity in PD fluids. Perit Dial Int 1996;16(suppl 1):S114-18.
9. 9 Dunn DL, Barke RA, Ahrenholz DH, et al. The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications. Ann Surg 1984;199:37-43.
10. 10 Verbrugh HA, Keane WF, Hoidal JR, et al. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 1983;147:1018-29.
11. 11 Topley N. What is the ideal technique for testing the biocompatibility of peritoneal dialysis solutions? Perit Dial Int 1995;15:205-9.
12. 12 Brulez HFH, Snijders SV, ter Wee PM, et al. A new in vitro model for the assessment of mesothelial cell function during peritoneal dialysis [abstract]. J Am Soc Nephrol 1997;8: 183A.
13. 13 Yang AH, Chen JY, Lin YP, et al. Peritoneal dialysis solution induces apoptosis of mesothelial cells. Kidney Int 1997;51:1280-8.
14. 14 Peterson PK, Verhoef J, Schmeling D, et al. Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes. J Infect Dis 1977;136:502-9.
15. 15 Klein E, Ward RA, Williams TE, et al. Peptides as substitute osmotic agent for glucose in peritoneal dialysate. ASAIO J 1986;32:550-3.
16. 16 Weber GF. The measurement of oxygen-derived free radicals and related substances in medicine. J Clin Chem Clin Biochem 1990;28:569-603.
17. 17 Clerc C, Piboun M, Ruelland A, et al. Cutaneous interstitial fluid protein concentrations in the inflammatory syndrome: pharmacological consequences. Clin Chim Acta 1990;189:181-90.
18. 18 Suassuna JH, Das Neves FC, Hartley RB, et al. Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. Kidney Int 1994;46:443-54.
19. 19 Zeillemaker AM, Mul FP, Hoynck van Papendrecht AA, et al. Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophil migration. Immunology 1995; 84:227-32.
20. 20 Krediet RT, Ho-Dac-Pannekeet MM, Struijk DG. Preservation of peritoneal membrane function. Kidney Int 1996; 50(suppl 56):S62-8.
21. 21 Lindholm B, Norbeck HE. Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis. Acta Med Scand 1986;220:143-51.
22. 22 Brulez HFH, Snijders SV, ter Wee PM, et al. In vitro biocompatibility of potential peritoneal dialysis fluids [abstract]. J Am Soc Nephrol 1997;7:1475.
23. 23 Brulez HFH, Snijders SV, ter Wee PM, et al. The impact of glycerol and polypeptides based solutions as potential peritoneal dialysis fluids on leukocyte function in vitro [abstract]. Perit Dial Int 1997;17(suppl 1):S28.
24. 24 Matsumoto T, van der Auwera P, Watanabe Y, et al. Neutrophil function in hyperosmotic NaCl is preserved by phosphoenol pyruvate. Urol Res 1991;19:223-7.
25. 25 Wright SD. Receptors for complement and the biology of phagocytosis. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation, 2nd ed. New York: Raven Press, 1992:477-95.
26. 26 Unkeles JC, Boros P, Fein M. Structure, signaling, and function of FcγR. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation, 2nd ed. New York: Raven Press, 1992:497-510.
27. 27 Kaupke CJ, Zhang J, Rajpoot D, et al. Effects of conventional peritoneal dialysates on leukocyte adhesion and CD11b, CD18 and CD14 expression. Kidney Int 1996;50:1676-83.
28. 28 Topley N, Mackenzie R, Petersen MM, et al. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant 1991;6:574-81.
29. 29 van Bronswijk H, Verbrugh HA, Heezius HCJM, et al. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1988;7:368-73.
30. 30 Brulez HFH, Heezius HCJM, de Fijter CW, et al. In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function. Adv Perit Dial 1994; 10:241-4.